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Methods reported including the official methods for determination of 
chloroquine in tablet samples use carcinogenic organic solvents. In this study, 
UV-Vis spectrometry using water as a solvent was developed for determination of 
chloroquine phosphate in pharmaceutical tablet dosage forms. The method was 
validated according to the International Conference on Harmonization (ICH) and 
USP guidelines. The absorbance of chloroquine phosphate in distilled water at max
of 343 nm showed linear dependence on concentration in the range 10.88-30.56 
µg mL-1 with determination coefficient of 0.99972. Recovery results in the range 
98.79–101.20% and low coefficient of variation values for intra-day and inter-
day precisions (0.37% and 0.76%, respectively) showed the accuracy and 
reproducibility of the method. The method was used for determination of 
chloroquine phosphate in tablet formulations of different brands. Results in the 
range 100.63–103.52% of the labeled chloroquine phosphate in tablet 
formulations confirmed the applicability of the developed method for real sample 
analysis. Hence, the developed UV-Vis method using environmentally friendly 
water as a solvent, with an excellent accuracy and precision showed that the 
developed method can be a potential substituent for the official reference 
methods.   
 
                 © 2017 International Scientific Organization: All rights reserved. 
Capsule Summary: UV-Vis spectrophotometry using water as a solvent showed an excellent precision and accuracy for the 
determination of chloroquine in pharmaceutical formulations. 
Cite This Article As: K. Desta and M. Amare. Validated UV-Visible spectrometry using water as a solvent for determination of 
chloroquine in tablet samples. Chemistry International 3(3) (2017) 288-295.  
 
INTRODUCTION 
 
Chloroquine phosphate (CQ) is an anti-malarial drug, which 
is absorbed rapidly and almost completely through 
gastrointestinal tract (Patel et al., 2005). It is the proto-type 
synthetic anti-malaria drug most widely used to treat all 
types of malaria infections, and when administrated orally; it 
is usually well tolerated and effective (Ali et al., 2009). 
The problem of malaria as a public health concern 
has continued to be highlighted by the high morbidity and 
mortality, and negative impact on socio-economic 
development in Africa (Chaulet et al., 1994; Trape, 2001; 
Celestino et al., 2003). It is a serious disease that can cause 
death if not treated right away. It is caused by a parasite that 
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can infect a certain type of mosquito which feeds on humans 
(Taneja et al., 2013). The outcome of treatment in malaria 
depends on the right diagnosis, selection of the right drug 
and its efficacy, correctness of the advice given to the patient 
and compliance of the patient (Bajpai and Jyoti, 2006; 
Anbarasan et al., 2013).  
Chloroquine phosphate has marked and rapid 
schizontocidal activity against all infections of Plasmodium 
malariae and Plasmodium ovale and against Chloroquine-
sensitive infections of Plasmodium falciparum and 
Plasmodium vivax. It is also gametocytocidal against 
Plasmodium vivax, Plasmodium malariae, and Plasmodium 
ovale as well as immature gametocytes of Plasmodium 
falciparum (Lawal et al., 2012). The drug is also indicated for 
the treatment of extra intestinal amoebiasis (Patel et al., 
2005). 
While the official British Pharmacopeia (BP) method 
for determination of chloroquine phosphate from 
pharmaceutical tablet formulation is potentiometric titration 
(Nelson et al., 2010; BP, 2013), the official United State 
Pharmacopeia (USP) method is UV-Vis spectrophotometric 
method (USP, 2007). Both official methods require extraction 
of chloroquine base from tablet samples using chloroform 
which is expensive and carcinogenic chemical besides 
lengthy procedure for sample treatment prior to analysis.   
On top of the reference official methods, many 
analytical methods; Spectrofluorimetry (Vogel and Konigk, 
1975; Adelusi and Salako, 1980; Anbarasan et al., 2013), 
Spectrophotometry (Patel et al., 2005; Ofokansi et al., 2009; 
Aitha, 2013), HPLC (Vogel and Konigk, 1975; Chaulet et al., 
1993; Abdelrahman et al., 1994; Walker and Ademowo, 1996; 
Paci et al., 2002; Patel et al., 2005; Samanidou et al, 2005), 
Gas chromatography (Bergquvist and Eckerbom, 1984), and 
Calorimetry (Kaseje and Brandling-Bennett, 1988) have been 
reported for determination of chloroquine phosphate from 
different dosage forms.    
Both the official methods and the other reported 
methods are all time consuming, environmental unfriendly, 
and cost-ineffective.  Moreover, many of the reported 
methods involve several steps making them tedious and time 
consuming for routine quality control analysis of the drug 
from its pharmaceutical formulations in manufacturing and 
regulatory laboratories. The solvents and reagents these 
methods use are expensive and/or environmentally 
hazardous. Thus, development of simple, environmentally 
friendly, and cost-effective method that could be used for the 
determination of chloroquine in complex matrix is vital. 
The aim of this work, therefore, is to develop a 
validated simple, time saving, environmentally friendly, and 
cost-effective UV-Vis spectrophotometric analytical method 
for the quantitative determination of chloroquine phosphate 
in its pharmaceutical tablet formulations using water as a 
solvent.  
MATERIAL AND METHODS 
Chemicals  
All reagents and chemicals used were of analytical grade 
which were used without further purification. Hydrochloric 
acid (36.5% w/v, Sigma-Aldrich, Germany) and Sulphuric 
acid (95-98%, Himedia laboratories Pvt. Ltd, India) were 
used. The active pharmaceutical ingredient in the tablet 
formulation, standard chloroquine phosphate (99.21%, B# 
3100C3RJ; IPCA laboratories Ltd, India), the inactive 
pharmaceutical ingredients in the tablet formulation; Maize 
Starch (B# STEX1408373; Devats, India ), Magnesium 
stearate (B# 20131109; Huzhou Zhammong pharmaceutical 
Co. Ltd, China) and purified Talc (B# 177;  Neelkanth Mine 
Chem., India) were used.  
Instruments 
A double-beam UV-Vis spectrophotometer (UV-1700 
Shimadzu, Japan) was used for absorbance measurement.  
Solution preparation  
Standard solution: A 3.40 mg mL-1 stock solution of 
chloroquine phosphate in water was prepared by taking 0.34 
g of standard chloroquine phosphate in 100 mL volumetric 
flask. About 60 mL of distilled water was first added and 
swirled for 5 minutes until the chloroquine phosphate is 
totally dissolved and finally diluted with the same solvent up 
to the mark. A clear solution of chloroquine phosphate in 
distilled water was obtained after filtration. 100 mL of 340 µg 
mL-1 intermediate standard solution of chloroquine 
phosphate in distilled water was prepared from the filtered 
stock solution.  
Working standard solutions of different 
concentrations (10.88, 12.24, 13.60, 14.96, 16.32, 21.24, and 
30.56 µg mL-1) were prepared from the intermediate 
standard solution by serial dilution with distilled water.  
Tablet sample solution: Chloroquine phosphate 
tablet samples of different brands (B#16968; APF, and 
B#3080723; EPHARM, both Ethiopian brands) labeled as 250 
mg/tablet were purchased from local pharmacies. Twenty 
tablets of each brand were accurately weighed and powdered 
using a clean mortar and pestle. For each brand, a quantity of 
the powder containing 0.34 g of chloroquine phosphate 
according to the label was transferred to 100 mL volumetric 
flask, dissolved in about 60 mL of distilled water and then 
diluted up to the mark with distilled water. A clear solution of 
tablet chloroquine phosphate in distilled water was obtained 
by filtration. A working tablet solution of 13.60 µg mL-1 was 
prepared by dissolving 10 mL of the filtrate in 100 mL of 
distilled water.   
A synthetic mixture was prepared by mixing 
appropriate amounts of the active pharmaceutical substance 
(chloroquine phosphate) and the In-active pharmaceutical 
substances (excipients). The sample solution of the synthetic 
mixture was prepared in the same way as tablet sample. 
Analytical methods 
In order to determine the wave length of maximum 
absorbance (λmax) of chloroquine phosphate, 13.60 μg mL-1 of 
the standard solution was scanned in the wave length range 
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400 to 230 nm against distilled water as a blank. The wave 
length corresponding to maximum absorbance (λmax) was 
found to be 343 nm which was used as the working 
wavelength (λmax) for determination of chloroquine 
phosphate in pharmaceutical formulations.  
The chloroquine phosphate content in two brands of 
tablet samples and synthetic tablet sample was determined 
spectrophotometrically using water as a solvent. For 
comparison purpose, the marketed tablet samples and 
laboratory prepared sample were analyzed following the 
standard reference procedure (USP, 2007). Briefly: twenty 
250 mg labeled tablets of each brand were weighed and 
finely powdered. An accurately weighed portion of the 
powder, equivalent to about 800 mg of chloroquine 
phosphate, was transferred to a 200 mL volumetric flask to 
which about 100 mL of distilled water was added and swirled 
mechanically for about 20 minutes. Distilled water was then 
added up to the mark, mixed, and then filtered using 
Whatman filter paper. 50 mL of the clear filtrate was pipette 
out into 250 mL separatory funnel to which 5 mL of 6 N 
ammonium hydroxide was added. After agitation, 
chloroquine phosphate was extracted using five successive 
25 mL portions of chloroform. The combined chloroform 
extract was washed with 10 mL of water, and the washing 
water was further extracted with 10 mL of chloroform. The 
combined chloroform extract was evaporated on a steam 
bath to about 10 mL, then added 50 mL of dilute hydrochloric 
acid (1 in 250), and continued heating on the steam bath until 
the odor of chloroform was no longer perceptible. The 
solution was transferred to a 200 mL volumetric flask, the 
evaporating vessel was washed with portions of dilute 
hydrochloric acid (1 in 1000), the washings was added to the 
volumetric flask and diluted stepwise up to the mark with 
dilute hydrochloric acid (1 in 1000) to obtain an estimated 
concentration of 10 µg mL-1. In the same manner, a standard 
sample solution was prepared by dissolving an accurately 
weighed, 400 mg, of USP chloroquine phosphate reference 
substance (purity = 99.21%) in dilute hydrochloric acid (1 in 
1000), and diluted quantitatively and stepwise with the same 
dilute hydrochloric acid to obtain a standard solution of 10 
µg mL-1concentration.  Concomitantly, the absorbance of both 
solutions was determined in 1cm cell at the maximum 
absorbance wavelength (343 nm) using dilute hydrochloric 
acid (1 in 1000) as the blank. The amount of chloroquine 
phosphate in the dosage formulations was calculated and 
recorded.   
Validation of the proposed method 
After selection of the suitable solvent and the wave length of 
maximum absorbance, the developed method was validated 
for the parameters; specificity, linearity, precision, accuracy, 
limit of detection and quantification, robustness / ruggedness 
and stability of analyte solution as per the International 
Conference on Harmonization ( ICH)24  and USP12 guidelines.    
 
RESULTS AND DISCUSSION 
Selection of suitable solvent 
Solubility of a drug is one of its important physico-chemical 
properties (Abolghasem and Mohammad, 2016). The 
solvent system should provide homogeneous solution 
where by all the solute substance under investigation is 
completely dissolved. The same concentrations of 
chloroquine phosphate were prepared using three different 
solvents (distilled water, 0.1 M HCl and 0.05 M H2SO4) and 
measured spectrophotometric absorbances are 
summarized in Table 1.  
As can be seen from the table, the mean 
absorbance of the analyte in distilled water is reasonable 
large with an improved precision than in the other solvents 
making distilled water as a best candidate solvent for the 
determination of chloroquine phosphate using UV-Vis 
spectrophotometer. So far, the methods is promising for the 
determination of chloroquine phosphate using water as 
solvent, which is non-toxic versus organic solvents. 
 
Method validation 
Interference study: In this study, the effect of excipients 
such as talc, starch, and magnesium stearate in the 
determination of chloroquine phosphate was investigated. 
Two solutions; one containing only chloroquine phosphate 
and the other containing a mixture of chloroquine 
phosphate and the excipients (placebo) both with similar 
chloroquine phosphate concentration were prepared. The 
UV-Vis absorbance for the two samples was recorded by 
scanning between 230 and 365 nm. The spectra were 
compared in terms of both the max and absorbance intensity 
(Fig. 1). As can be seen from the Figure, presence of the 
excipients (curve b of figure 1) did not show any additional 
max
 nor significantly affect the absorbance intensity of the 
analyte at its characteristic max  (343 nm). The presence of 
the potential interferents (excipients) caused an error of 
less than 2% which still is tolerable (Tulasamma and 
Venkateswarlu, 2012). Therefore, the proposed UV-Vis 
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Fig. 1: UV-Vis spectra of standard and mixture 
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method for determination of chloroquine phosphate using 
water as a solvent showed its potential applicability for 
determining chloroquine phosphate in tablet formulations 
without significant interference from the drug matrix.        
 Linearity: Five standard concentrations of 
chloroquine phosphate in distilled water (10.88, 12.24, 
13.60, 14.96, 16.32, 21.24, and 30.56 µg mL-1) in the range 
80-120% of the analyte in the tablet (Gandhimathi et al., 
2012) were prepared. For each standard solution, triplicate 
absorbances at 343 nm against distilled water as a blank 
were recorded. Mean absorbance showed linear 
dependence on the concentration of chloroquine phosphate 
in the range 10.88–30.56 μg mL-1 with a linear regression 
equation and determination coefficient (R2) of A = 0.3828C 
(µg mL-1) - 0.0391 and 0.99972, respectively. 
Precision: Precision of the method was evaluated 
as discussed under the experimental part. In all cases, six 
replicate measurements were made for a 13.6 µg mL-1 
standard chloroquine phosphate solution and the standard 
and percentage relative standard deviations (%RSD) for 
each were calculated. As can be seen from Table 2, the 
calculated coefficient of variation in the three cases 
(repeatability, intra-day, and inter-day results) was found 
to be within the acceptable limit range Satisfactorily low 
Table 1: Selection of suitable solvent for UV-Vis spectrophotometric determination of chloroquine phosphate 
Solvent                  Absorbance Mean RSD (%) 
Trial-1* Trial-2* Trial-3* 
Distilled water 0.4827 0.4814 0.4829 0.4823 0.166 
0.1 M HCl 0.4778 0.4778 0.4799 0.4785 0.251 
0.05 M H2SO4 0.4941 0.4956 0.4974 0.4957 0.343 
*average of three determinations 
 
Table 2: Precision studies of the developed method for determination of chloroquine phosphate 
Sample No. Repeatability Intra-day 
Precision 
                      Inter-day precision 
Day-1 Day-2 Day-3 
   1   0.4742   0.4807   0.4852   0.4858     0.4916 
   2   0.4734   0.4855   0.4856   0.4880                              0.4888 
   3   0.4745   0.4823   0.4877   0.4855     0.4907 
   4   0.4742   0.4806   0.4836   0.4889     0.4946 
   5   0.4740   0.4816   0.4836   0.4860     0.4943 
6   0.4734   0.4819   0.4851   0.4863     0.4950 
Mean    0.4740   0.4821   0.4851   0.4868     0.4925 
SD*   0.0005   0.0018   0.0015   0.0014     0.0025 
RSD** (%)    0.1056   0.3733   0.3092   0.2876     0.5076 
* standard deviation; ** relative standard deviation within a day 
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coefficients of variation suggested high level of precision 
and hence suitability of the developed method for 
determination of chloroquine phosphate in pharmaceutical 
formulations using water as a solvent. 
Accuracy: The accuracy of the proposed method for 
determination of chloroquine in pharmaceutical tablet 
samples was evaluated by performing recovery studies of 
standard chloroquine from three synthetic chloroquine 
phosphate tablet formulation. 6.8, 13.6, and 20.4 µg mL-1 
concentration of standard chloroquine (50, 100 and 150% 
of the chloroquine phosphate tablet label) were prepared 
and mixed with the excipients.  After recording triplicate 
absorbance measurements for each sample, the 
corresponding concentration was calculated using the 
formulated regression equation. As shown in Table 3, 
excellent recoveries in the range 98.79 ± 0.11 - 101.20 ± 
 
Table 3: Recovery results of spiked chloroquine phosphate from pharmaceutical formulations 
Sample No. Added 
(µgmL-1) 
Measured 
Absorbance 
Found 
(µgmL-1) 
Mean* (µgmL-1)  
± SD 
 
%Recovery± RSD 
1 6.8 0.2336 
 
6.90 
 
6.87± 0.05 
100.98 ± 0.72 
 
0.2330 
 
6.89 
 
0.2302 6.81 
2 13.6 0.4891 
 
13.76 
 
13.76±0.03 
101.20 ± 0.19 
 
0.4882 
 
13.74 
 
0.4902 13.79 
3 20.4 0.7284 
 
20.18 
 
20.15± 0.02 
98.79 ± 0.11 
 
 0.7269 
 
20.14 
 
0.7267 20.14 
* average of three determinations; SD standard deviation; RSD % relative standard deviation 
 
 
 
Table 4: Chloroquine phosphate content in APF (tablet-1), EPHARM (tablet-2) brands of tablet formulations and 
synthetic tablet samples using the proposed and USP official methods   
 
Sample 
Proposed method* Official (USP) method* ** 
t-test 
** 
F-test 
Assay (%) ± SD Assay (%) ± SD 
 
Tablet-1 101.27 ± 0.22 
 
101.40 ± 0.24 
 
0.694 1.16 
Tablet-2 103.52 ± 0.33 
 
101.78 ± 0.12 
 
1.74 8.26 
Synthetic mixture 100.63 ± 0.24 
 
101.18 ± 0.17 
 
0.17 1.95 
*mean of three determinations; **tabulated values of t and F at 95% are 4.30 and 19.0, respectively 
 
 
  Table 5: Comparison between the proposed and the reference spectrophotometric methods 
      Parameters Proposed method Reference method 
Chemicals (solvent) used Distilled water  CHCl3 and dil. HCl  
Total time of analysis Max. 30 minutes Min. 5 hours  
Safety of the chemicals used Environmentally friendly Environmentally unfriendly 
Cost Cost-effective Cost-ineffective 
 
ISSN: 2410-9649                                   Desta and Amare / Chemistry International 3(3) (2017) 288-295 iscientic.org.  
293 
www.bosaljournals/chemint/                               editorci@bosaljournals.com 
0.19% indicated the accuracy of the developed method and 
hence its applicability for the determination of chloroquine 
phosphate in tablet formulations.  
Limit of detection (LOD) and Limit of quantification 
(LOQ): Method LOD and LOQ were calculated using the 
standard deviation of replicate absorbance measurement (n 
= 7) of a blank sample at wave length of 343 nm and the 
slope of the calibration curve for seven data points as 0.073, 
and 0.220 µg mL-1, respectively.  
Robustness and ruggedness: The 
robustness/ruggedness of the developed method was 
evaluated by comparing the results for the same solution by 
two analysts.  An extremely small variation (0.0012) 
between the mean results generated by the two analysts 
each with low %RSD (0.31 and 0.28%)  (data not shown) 
indicated the robustness/ruggedness of the method.  
Stability of analyte solution: The effect of analysis 
time on both the physical appearance and absorbance of 
the chloroquine phosphate tablet sample in water was 
evaluated. Analyses were conducted every 4 hours interval 
and absorbance results (data not shown) showed no time 
dependency indicating the stability of chloroquine 
phosphate in water.  
Therefore, absorbance measurements of 
chloroquine phosphate solution using water as a solvent 
showed no significant dependence on the analysis time.   
Hence, the analyte solution was found to be stable up to 24 
hours at normal laboratory working conditions with 
acceptable coefficient of variations (0.7044% and 0.7256% 
for standard and sample solutions, respectively).   
 
Chloroquine phosphate in pharmaceutical 
preparations 
The applicability of the proposed method for the 
determination of chloroquine phosphate in commercial 
tablet dosage forms was examined by analyzing marketed 
products and laboratory prepared sample (synthetic 
mixtures). The marketed Ethiopian tablet brands were 
chloquine-250 mg tablet of Addis pharmaceutical factory 
(APF) and Ethiopian pharmaceutical manufacturing 
(EPHARM).  
The assay analysis of the marketed tablet and the 
laboratory prepared synthetic mixture samples were 
quantitatively analyzed using the new proposed method as 
per the procedure described under the experimental 
section of this manuscript.  Assay chloroquine phosphate 
values for each sample were calculated taking the 
respective mean absorbance measured using the developed 
method and the USP official method (USP, 2007).                 
The results obtained for this analysis (Table 4) 
were statistically compared with the result obtained using 
the USP official method by calculating the statistical t & F 
values. As can be seen from the table, the experimental 
statistical values were less than the respective tabulated 
theoretical values confirming that the results obtained 
using the developed method are similar with the result 
obtained using the official method. Thus, the proposed 
method which is environmental friendly can be an excellent 
substituent method for the official method which uses 
organic solvent for the determination of chloroquine 
phosphate in pharmaceutical tablet dosage forms.  
 
Comparison between the proposed and reference 
spectrophotometric methods 
Comparison between the developed method and the 
reference method was made in terms of the time needed for 
analysis and cost of analysis. The comparison showed that 
the proposed spectrophotometric method was both time 
and cost effective over the conventional extraction method. 
The total time required for the analysis of a sample 
following the proposed method was found to be much 
shorter and cheaper than the reference (extraction) method 
as shown in Table 5.  
The developed UV-Vis spectrophotometric method 
uses 572 mL of distilled water for both sample and 
standard preparations as a solvent whereas the extraction 
method uses 125 mL of chloroform, 100 mL of distilled 
water and 720 mL of dilute HCl which makes them to differ 
greatly in their cost of analysis.  
 
CONCLUSIONS 
 
A simple UV-Vis spectrophotometric method using cheap 
and environmental friendly water as a solvent was 
developed for the determination of chloroquine phosphate 
in its pharmaceutical tablet dosage form. Its absorbance 
was measured at maximum absorbance of 343 nm against 
the corresponding reagent blank. The developed method is 
simple, precise, reproducible, accurate, specific, economic 
and less time consuming. The method has also been 
statistically evaluated and the results obtained are accurate, 
precise and free from the interferences of other additives or 
excipients present in the formulation. There was no 
interference from the excipients used in the tablet 
formulations and hence the method is suitable for analysis 
of formulated tablets.  
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